XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue [1] $ 319,939 $ 222,057 $ 616,996 $ 437,128
Expenses        
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) [1] 249,705 172,113 469,444 329,945
Selling, general and administrative expenses [1] 58,955 42,699 117,887 101,290
Depreciation and amortization expenses 15,112 14,916 30,218 30,103
Change in fair value of contingent consideration 800 0 6,878 (594)
Total operating expenses 324,572 229,728 624,427 460,744
Operating loss (4,633) (7,671) (7,431) (23,616)
Interest income 223 68 340 191
Interest expense (2,148) (6,274) (4,389) (12,611)
Gain from equity method investees 1,952 4,879 2,548 12,662
Gain on transfer of membership 0 0 0 22,969
Loss on repayment of debt, net 0 0 0 (19,158)
Other income (expense), net 297 (18) 475 (32)
Loss from continuing operations before income taxes (4,309) (9,016) (8,457) (19,595)
Provision for (benefit from) income taxes (184) 91 1,018 702
Loss from continuing operations (4,125) (9,107) (9,475) (20,297)
Income (loss) from discontinued operations, net of tax [2] (463) 0 (463) 1,383
Net loss attributable to common shareholders of Evolent Health, Inc. - Basic (4,588) (9,107) (9,938) (18,914)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ (4,588) $ (9,107) $ (9,938) $ (18,914)
Basic        
Continuing operations (in dollars per share) $ (0.05) $ (0.11) $ (0.11) $ (0.24)
Discontinued operations (in dollars per share) 0 0 0 0.02
Basic loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) (0.05) (0.11) (0.11) (0.22)
Diluted        
Continuing operations (in dollars per share) (0.05) (0.11) (0.11) (0.24)
Discontinued operations (in dollars per share) 0 0 0 0.02
Diluted loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ (0.05) $ (0.11) $ (0.11) $ (0.22)
Weighted-average common shares outstanding        
Basic (in shares) 90,071 85,448 89,792 85,056
Diluted (in shares) 90,071 85,448 89,792 85,056
Comprehensive income (loss)        
Net loss $ (4,588) $ (9,107) $ (9,938) $ (18,914)
Other comprehensive loss, net of taxes, related to:        
Foreign currency translation adjustment (288) (58) (420) (89)
Total comprehensive loss attributable to common shareholders of Evolent Health, Inc. $ (4,876) $ (9,165) $ (10,358) $ (19,003)
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.
[2] Includes $(0.5) million loss on disposal for the three and six months ended June 30, 2022 and $1.9 million gain on disposal of discontinued operations for the six months ended June 30, 2021, respectively